Recap: Repare Therapeutics Q4 Earnings

Repare Therapeutics RPTX reported its Q4 earnings results on Wednesday, February 28, 2024 at 07:05 AM.

Here's what investors need to know about the announcement.

Repare Therapeutics missed estimated earnings by -46.0%, reporting an EPS of $-0.67 versus an estimate of $-0.46.

Revenue was down $5.15 million from the same period last year.

Last quarter the company beat on EPS by $0.41 which was followed by a 5.0% increase in the share price the next day.

Here's a look at Repare Therapeutics's past performance:

Quarter	Q3 2023	Q2 2023	Q1 2023	Q4 2022
EPS Estimate	-0.86	-0.78	-0.81	-0.97
EPS Actual	-0.45	-0.28	-0.83	-0.75
Revenue Estimate	6.31M	7.68M	6.12M	10.83M
Revenue Actual	2.16M	30.25M	5.68M	18.20M

** Listen to the earnings announcement yourself by clicking here. **

To track all earnings releases for Repare Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar